Rat bone marrow mesenchymal stem cells differentiate into hepatocytes in vitro

Area of Science:

• Stem Cell Biology
• Hepatology
• Regenerative Medicine

Background:

• Mesenchymal stem cells (MSCs) are multipotent stem cells with potential therapeutic applications.
• Hepatic diseases require effective cell-based therapies.
• Identifying novel sources for hepatocyte differentiation is crucial for liver disease treatment.

Purpose of the Study:

• To investigate the differentiation mechanism of bone marrow MSCs into hepatocytes.
• To explore the regulatory factors involved in this differentiation process.
• To establish a new cell source for hepatic disease therapies.

Main Methods:

• Isolation of MSCs from rat bone marrow using gradient density centrifugation and plastic adherence.
• Culture of MSCs in specific differentiation media supplemented with hepatocyte growth factor (HGF) and fibroblast growth factor-4 (FGF-4).
• Assessment of differentiation through morphological changes, histochemical staining (Periodic acid-Schiff), and biochemical assays for albumin, alpha-fetoprotein (AFP), and urea.

Main Results:

• A homogeneous population of MSCs was successfully isolated and characterized.
• Culturing MSCs with HGF and FGF-4 induced morphological changes consistent with hepatocyte differentiation in approximately 56.6% of cells.
• Significant increases in AFP, albumin, and urea levels, along with glycogen storage, were observed, confirming hepatocyte-like function.

Conclusions:

• Gradient density centrifugation combined with plastic adherence is an effective method for isolating MSCs.
• Rat MSCs can be differentiated into functional hepatocytes using HGF and FGF-4.
• Cytokines play a significant role in regulating MSC differentiation into hepatocytes, offering a promising avenue for cell-based liver therapies.